Source: International Congress 2015 – Treatment and control of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sarah Landis (Uxbridge, United Kingdom), Sarah Landis, Robert Suruki, Nicolas Galwey. LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink. Eur Respir J 2015; 46: Suppl. 59, 4047

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Continuing to confront COPD international physician survey Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: An algorithm for the identification of clinical COPD phenotypes in daily practice Source: International Congress 2016 – COPD diagnosis and management Year: 2016 LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 LATE-BREAKING ABSTRACT: COPD healthcare research: Multicentre study on COPD out-patient healthcare in Germany (ORCAS) Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 LATE-BREAKING ABSTRACT: Network-based meta-analysis of lung, sputum and blood transcriptomics in COPD Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Microbiology and radiology of pneumonia in COPD Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 LATE-BREAKING ABSTRACT: Effect of fluticasone furoate (FF)/vilanterol (VI) on the rate of COPD exacerbations in everyday clinical practice: Results of the COPD Salford lung study (SLS) Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 LATE-BREAKING ABSTRACT: Lung function assessed by home forced oscillation and self reported symptoms during COPD exacerbations Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015